newsfilter
← Latest News
Earnings Call Transcripts·

MBRX_Market Potential_07.06.26 - JTC TEAM

We do think that the new phase 3 data clearly raises confidence in the likelihood that anamycin will be approved for use in AML. But look, a reasonable follow-on question is whether that will translate into significant c